102 related articles for article (PubMed ID: 9272764)
1. Platelet serotonin and [3H]paroxetine binding correlate with recurrence of suicidal behavior.
Verkes RJ; Fekkes D; Zwinderman AH; Hengeveld MW; Van der Mast RC; Tuyl JP; Kerkhof AJ; Van Kempen GM
Psychopharmacology (Berl); 1997 Jul; 132(1):89-94. PubMed ID: 9272764
[TBL] [Abstract][Full Text] [Related]
2. Platelet serotonin, monoamine oxidase activity, and [3H]paroxetine binding related to impulsive suicide attempts and borderline personality disorder.
Verkes RJ; Van der Mast RC; Kerkhof AJ; Fekkes D; Hengeveld MW; Tuyl JP; Van Kempen GM
Biol Psychiatry; 1998 May; 43(10):740-6. PubMed ID: 9606528
[TBL] [Abstract][Full Text] [Related]
3. Hypodensity of platelet serotonin uptake sites in posttraumatic stress disorder: associated clinical features.
Fichtner CG; O'Connor FL; Yeoh HC; Arora RC; Crayton JW
Life Sci; 1995; 57(2):PL37-44. PubMed ID: 7603291
[TBL] [Abstract][Full Text] [Related]
4. Circannual variations in the binding of [3H]lysergic acid diethylamide to serotonin2A receptors and of [3H]paroxetine to serotonin uptake sites in platelets from healthy volunteers.
Spigset O; Allard P; Mjörndal T
Biol Psychiatry; 1998 May; 43(10):774-80. PubMed ID: 9606533
[TBL] [Abstract][Full Text] [Related]
5. Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment.
Hrdina PD; Bakish D; Ravindran A; Chudzik J; Cavazzoni P; Lapierre YD
Psychiatry Res; 1997 Feb; 66(2-3):73-85. PubMed ID: 9075272
[TBL] [Abstract][Full Text] [Related]
6. Paroxetine binding in the blood platelets of post-traumatic stress disorder patients.
Arora RC; Fichtner CG; O'Connor F; Crayton JW
Life Sci; 1993; 53(11):919-28. PubMed ID: 8366759
[TBL] [Abstract][Full Text] [Related]
7. Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment.
Bixo M; Allard P; Bäckström T; Mjörndal T; Nyberg S; Spigset O; Sundström-Poromaa I
Psychoneuroendocrinology; 2001 Aug; 26(6):551-64. PubMed ID: 11403977
[TBL] [Abstract][Full Text] [Related]
8. Platelet 5-HT2A receptor binding and tryptophan availability in depression are not associated with recent history of suicide attempts but with personality traits characteristic for suicidal behavior.
Lauterbach E; Brunner J; Hawellek B; Lewitzka U; Ising M; Bondy B; Rao ML; Frahnert C; Rujescu D; Müller-Oerlinghausen B; Schley J; Heuser I; Maier W; Hohagen F; Felber W; Bronisch T
J Affect Disord; 2006 Mar; 91(1):57-62. PubMed ID: 16412522
[TBL] [Abstract][Full Text] [Related]
9. Platelet serotonergic functions and light therapy in seasonal affective disorder.
Stain-Malmgren R; Kjellman BF; Aberg-Wistedt A
Psychiatry Res; 1998 May; 78(3):163-72. PubMed ID: 9657420
[TBL] [Abstract][Full Text] [Related]
10. Platelet serotonin measures in primary dysthymia.
Ravindran AV; Chudzik J; Bialik RJ; Lapierre YD; Hrdina PD
Am J Psychiatry; 1994 Sep; 151(9):1369-71. PubMed ID: 8067494
[TBL] [Abstract][Full Text] [Related]
11. Platelet [3H]paroxetine binding, 5-HT-stimulated Ca2+ response, and 5-HT content in winter seasonal affective disorder.
Ozaki N; Rosenthal NE; Mazzola P; Chiueh CC; Hardin T; Garcia-Borreguero D; Schwartz PJ; Turner E; Oren DA; Murphy DL
Biol Psychiatry; 1994 Oct; 36(7):458-66. PubMed ID: 7811842
[TBL] [Abstract][Full Text] [Related]
12. Significant correlation between 14C-5-HT uptake by and 3H-paroxetine binding to platelets from healthy volunteers.
Maguire K; Tuckwell V; Pereira A; Dean B; Singh B
Biol Psychiatry; 1993 Sep; 34(6):356-60. PubMed ID: 8218602
[TBL] [Abstract][Full Text] [Related]
13. Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but not major depression.
Verkes RJ; Van der Mast RC; Hengeveld MW; Tuyl JP; Zwinderman AH; Van Kempen GM
Am J Psychiatry; 1998 Apr; 155(4):543-7. PubMed ID: 9546002
[TBL] [Abstract][Full Text] [Related]
14. Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet.
Coccaro EF; Kavoussi RJ; Sheline YI; Lish JD; Csernansky JG
Arch Gen Psychiatry; 1996 Jun; 53(6):531-6. PubMed ID: 8639036
[TBL] [Abstract][Full Text] [Related]
15. The relationship of platelet 5-HT2 receptor indices to major depressive disorder, personality traits, and suicidal behavior.
McBride PA; Brown RP; DeMeo M; Keilp J; Mieczkowski T; Mann JJ
Biol Psychiatry; 1994 Mar; 35(5):295-308. PubMed ID: 8011798
[TBL] [Abstract][Full Text] [Related]
16. Impaired platelet [3H]paroxetine binding in female patients with borderline personality disorder.
Ng Ying Kin NM; Paris J; Schwartz G; Zweig-Frank H; Steiger H; Nair NP
Psychopharmacology (Berl); 2005 Nov; 182(3):447-51. PubMed ID: 16052363
[TBL] [Abstract][Full Text] [Related]
17. Peripheral serotonergic markers in acutely suicidal patients. 1. Comparison of serotonergic platelet measures between suicidal individuals, nonsuicidal patients with major depression and healthy subjects.
Roggenbach J; Müller-Oerlinghausen B; Franke L; Uebelhack R; Blank S; Ahrens B
J Neural Transm (Vienna); 2007; 114(4):479-87. PubMed ID: 16988795
[TBL] [Abstract][Full Text] [Related]
18. Suicidality, circadian activity rhythms and platelet serotonergic measures in patients with recurrent suicidal behaviour.
Verkes RJ; Kerkhof GA; Beld E; Hengeveld MW; van Kempen GM
Acta Psychiatr Scand; 1996 Jan; 93(1):27-34. PubMed ID: 8919326
[TBL] [Abstract][Full Text] [Related]
19. High affinity [3H]imipramine and [3H]paroxetine binding sites in suicide brains.
Rosel P; Arranz B; Vallejo J; Oros M; Menchón JM; Alvarez P; Navarro MA
J Neural Transm (Vienna); 1997; 104(8-9):921-9. PubMed ID: 9451724
[TBL] [Abstract][Full Text] [Related]
20. Platelet 5-HT uptake sites in depression: three concurrent measures using [3H] imipramine and [3H] paroxetine.
Lawrence KM; Falkowski J; Jacobson RR; Horton RW
Psychopharmacology (Berl); 1993; 110(1-2):235-9. PubMed ID: 7870891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
